Serum prostate-specific antigen but not testosterone levels decrease in a randomized soy intervention among men

European Journal of Clinical Nutrition

Volumn 60, Issue 12, 2006, Pages 1423-1429

  Maskarinec, G ^a   Morimoto, Y ^a   Hebshi, S ^a   Sharma, S ^a   Franke, A A ^a   Stanczyk, F Z ^a,b  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOFLAVONE; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DIET THERAPY; FOOD INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; PATIENT COMPLIANCE; PILOT STUDY; PROSTATE CANCER; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SOYBEAN; TESTOSTERONE BLOOD LEVEL; URINE LEVEL;

CROSS-OVER STUDIES; HUMANS; ISOFLAVONES; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PILOT PROJECTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOIMMUNOASSAY; SOY FOODS; TESTOSTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 33845245175     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602473     Document Type: Article

References (45)

1. Adlercreutz H, Honjo H, Higashi A (1991). Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 54, 1093-1100.
2. Atkinson C, Skor HE, Fitzgibbons ED, Scholes D, Chen C, Wahala K et al. (2002). Overnight urinary isoflavone excretion in a population of women living in the United States, and its relationship to isoflavone intake. Cancer Epidemiol Biomarkers Prev 11, 253-260.
3. Blair RM, Appt SE, Franke AA, Clarkson TB (2003). Treatment with antibiotics reduces plasma equol concentration in cynomolgus monkeys (Macaca fascicularis). J Nutr 133, 2262-2267.
4. Center for Nutrition Policy and Promotion (1996). The Food Guide Pyramid. United States Department of Agriculture, Washington, DC.
5. Chen Z, Zheng W, Custer LJ, Dai Q Shu XO, Jin F et al. (1999). Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr Cancer 33, 82-87.
6. Dai Q, Franke AA, Jin F, Shu XO, Hebert JR, Custer LJ et al. (2002). Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev 11, 815-821.
7. Dillingham BL, McVeigh BL, Lampe JW, Duncan AM (2005). Soy protein isolates of varying isoflavone content exert minor effects on serum reproductive hormones in healthy young men. J Nutr 135, 584-591.
8. Ferlay J, Bray F, Pisani P, Parkin DM (2001). GLOBOCAN 2000: Cancer Incidence Mortality Prevalence Worldwide (1.0 IARC CancerBase No. 5). IARC Press: Lyon.
9. Franke AA, Custer LJ, Cerna CM, Narala K (1995). Rapid HPLC analysis of dietary phytoestrogens from legumes and from human urine. Proc Soc Exp Biol Med 208, 18-26.
10. Franke AA, Custer LJ, Wang W, Shi SJ (1998). HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc Soc Exp Biol Med 217, 263-273.
11. Franke AA, Hankin JH, Yu MC, Maskarinec G, Low SH, Custer LJ (1999). Isoflavone levels in soy foods consumed by multiethnic populations in Singapore and Hawaii. J Agric Food Chem 47, 977-986.
12. Gardner-Thorpe D, O'Hagen C, Young I, Lewis SJ (2003). Dietary supplements of soya flour lower serum testosterone concentrations and improve markers of oxidative stress in men. Eur J Clin Nutr 57, 100-106.
13. Goebelsmann U, Bernstein GS, Gale JA, Kletzky OA, Nakamura RM, Coulson AH et al. (1979). Serum gonadotropin, testosterone, estradiol, and estrone levels prior to and following bilateral vasectomy. In: Lepow JH (ed). Vasectomy: Immunologic and Pathophysiologic Effects in Animals and Man pp. 165-175. Academic Press: New York.
14. Habito RC, Montalto J, Leslie E, Ball MJ (2000). Effects of replacing meat with soyabean in the diet on sex hormone concentrations in healthy adult males. Br J Nutr 84, 557-563.
15. Hawaii Health Information Corporation (2004). Health trends in Hawaii: A Profile of the Health Care System. http://www.healthtrends.org/ (6th). pp. 1-14.
16. Hedlund TE, Maroni PD, Ferucci PG, Dayton R, Barnes S, Jones K et al. (2005). Long-term dietary habits affect soy isoflavone metabolism and accumulation in prostatic fluid in caucasian men. J Nutr 135, 1400-1406.
17. Kampmann J, Siersbaek-Nielsen K, Kristensen M, Hansen JM (1974). Rapid evaluation of creatinine clearance. Acta Med Scand 196, 517-520.
18. Karr SC, Lampe JW, Hutchins AM, Slavin JL (1997). Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption. Am J Clin Nutr 66, 46-51.
19. Kelly GE, Nelson C, Warin WA, Joannou GE, Reeder AY (1993). Metabolites of dietary (soya) isoflavones in human urine. Clin Chim Acta 223, 9-22.
20. Knudsen N, Christiansen E, Brandt-Christensen M, Nygaard B, Perrild H (2000). Age- and sex-adjusted iodine/creatinine ratio. A new standard in epidemiological surveys? Evaluation of three different estimates of iodine excretion based on casual urine samples and comparison to 24h values. Eur J Clin Nutr 54, 361-363.
21. Kolonel LN, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, Wilkens LR et al. (2000). Vegetables, fruits, legumes and prostate cancer: A multiethnic case-control study. Cancer Epidemiol Biomarkers Prev 9, 795-804.
22. Kranse R, Dagnelie PC, van Kemenade MC, de Jong FH, Blom JH, Tijburg LB et al. (2005). Dietary intervention in prostate cancer patients: PSA response in a randomized double-blind placebo-controlled study. Int J Cancer 113, 835-840.
23. Kumar NB, Cantor A, Allen K, Riccardi D, Besterman-Dahan K, Seigne J et al. (2004). The specific role of isoflavones in reducing prostate cancer risk. Prostate 59, 141-147.
24. Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R, Elgavish A (2002). Genistein chemoprevention: Timing and mechanisms of action in murine mammary and prostate. J Nutr 132, 552S-558S.
25. Lieberman R (2004). Evidence-based medical perspectives: The evolving role of PSA for early detection, monitoring of treatment response, and as a surrogate end point of efficacy for interventions in men with different clinical risk states for the prevention and progression of prostate cancer. Am J Ther 11, 501-506.
26. Littell RC, Milliken GA, Stroup WW, Wolfinger RD (1996). SAS System for Mixed Models. SAS Institute Inc., Cary, NC.
27. Makela S, Pylkkanen L, Santti R, Adlercreutz H (1991). Role of plant estrogens in normal and estrogen-related altered growth of the mouse prostate. In: Proceedings of the Interdisciplinary Conference on Effects of Food on the Immune and Hormonal Systems: Euro Food Tox III, Schwerzenbach, Switzerland: Institute of Toxicology, Swiss Federal Institute of Technology & University of Zurich, 135-139.
28. Maskarinec G, Robbins C, Riola B, Kane-Sample L, Franke A, Murphy S (2003). Three measures show high compliance in soy intervention among premenopausal women. J Am Diet Assoc 103, 861-866.
29. Maskarinec G, Singh S, Meng L, Franke AA (1998). Dietary soy intake and urinary isoflavone excretion among women from a multiethnic population. Cancer Epidemiol Biomarkers Prev 7, 613-619.
30. Murphy SP (2002). Unique nutrition support for research at the Cancer Research Center of Hawaii. Hawaii Med J 61, 15-17.
31. Nagata C, Inaba S, Kawakami N, Kakizoe T, Shimizu H (2000). Inverse association of soy product intake with serum androgen and estrogen concentrations in Japanese men. Nutr Cancer 36, 14-18.
32. Ritchie MR, Morton MS, Deighton N, Blake A, Cummings JH (2004). Plasma and urinary phyto-oestrogens as biomarkers of intake: Validation by duplicate diet analysis. Br J Nutr 91, 447-457.
33. Ryokkynen A, Nieminen P, Mustonen AM, Pyykonen T, Asikainen J, Hanninen S et al. (2005). Phytoestrogens alter the reproductive organ development in the mink (Mustela vison). Toxicol Appl Pharmacol 202, 132-139.
34. Sharma S, Murphy SP, Wilkens LR, Au D, Shen L, Kolonel LN (2003). Extending a multiethnic food composition table to include standardized food group servings. J Food Compos Anal 16, 485-495.
35. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM (1991). Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 63, 963-966.
36. Strom SS, Yamamura Y, Duphorne CM, Spitz MR, Babaian RJ, Pillow PC et al. (1999). Phytoestrogen intake and prostate cancer: A case-control study using a new database. Nutr Cancer 33, 20-25.
37. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL et al. (2004). Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. N Engl J Med 350, 2239-2246.
38. Troyer DA, Mubiru J, Leach RJ, Naylor SL (2004). Promise and challenge: Markers of prostate cancer detection, diagnosis and prognosis. Dis Markers 20, 117-128.
39. United States Department of Agriculture (2002). USDA-Iowa State University Database on the Isoflavone Content of Foods. http://www.nal.usda.gov/fnic/foodcomp/Data/isoflav/isoflav.html (Release 1.3). 6-23-2005.
40. US Department of Agriculture, Agricultural Research Service (2003). USDA National Nutrient Database for Standard Reference, Release 14. http://www.nal.usda.gov/fnic/foodcomp/index.htm14-30-2003.
41. Wakai K, Egami I, Kato K, Kawamura T, Tamakoshi A, Lin Y et al. (1999). Dietary intake and sources of isoflavones among Japanese. Nutr Cancer 33, 139-145.
42. Wang S, DeGroff VL, Clinton SK (2003). Tomato and soy polyphenols reduce insulin-like growth factor-I-stimulated rat prostate cancer cell proliferation and apoptotic resistance in vitro via inhibition of intracellular signaling pathways involving tyrosine kinase. J Nutr 133, 2367-2376.
43. Williams AE, Maskarinec G, Hebshi S, Oshiro C, Murphy S, Franke AA (2003). Validation of a soy questionnaire with repeated dietary recalls and urinary isoflavone assessments over one year. Nutr Cancer 47, 118-125.
44. Yamamoto S, Sobue T, Sasaki S, Kobayashi M, Arai Y, Uehara M et al. (2001). Validity and reproducibility of a self-administered food-frequency questionnaire to assess isoflavone intake in a Japanese population in comparison with dietary records and blood and urine isoflavones. J Nutr 131, 2741-2747.
45. Zheng W, Dia Q, Custer LJ, Shu XO, Wen WQ, Jin F et al. (1999). Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 8, 35-40.